Related Experiment Video
Updated: Jul 1, 2025
Immunohistochemical Staining of B7-H1 PD-L1 on Paraffin-embedded Slides of Pancreatic Adenocarcinoma Tissue
Published on: January 3, 2013
Humoral immunoprofiling identifies novel biomarkers and an immune suppressive autoantibody phenotype at the site of
Pamela Winnie M Maimela1, Muneerah Smith1, Andrew J M Nel1
1Department of Integrative Biomedical Sciences, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
This study reveals distinct autoantibody profiles in pancreatic cancer patients, identifying potential biomarkers for early detection. Local immune responses in tumors differ significantly from systemic responses, suggesting immune suppression.
Area of Science:
- Immunology
- Oncology
- Proteomics
Background:
- Pancreatic ductal adenocarcinoma (PDAC) is a deadly cancer with poor therapeutic response and late diagnosis.
- Understanding PDAC immunology is crucial for developing effective treatments and early detection strategies.
Purpose of the Study:
- To investigate autoantibody responses against cancer-testis and tumor-associated antigens in PDAC.
- To compare humoral immune responses in serum and tumor microenvironment using an immunoproteomic approach.
Main Methods:
- Utilized a high-throughput multiplexed protein microarray platform to analyze IgG and IgA antibody isotypes and subclasses.
- Compared antibody profiles in serum and tissue samples from PDAC patients, disease controls, and healthy individuals.
Main Results:
- Tumor tissue showed predominantly immune-suppressive IgG4 and inflammatory IgA2, contrasting with IgG3 and IgA1 in matched sera.
- Identified candidate serum autoantibody biomarker panels: top IgG panel (ACVR2B, GAGE1, LEMD1, MAGEB1, PAGE1) and top IgA panel (AURKA, GAGE1, MAGEA10, PLEKHA5, XAGE3aV1).
- Observed abundant sialylation on IgA in PDAC, indicating an immune-suppressive IgA response.
Conclusions:
- PDAC exhibits unique local and systemic autoantibody profiles, suggesting localized immune tolerance.
- Discovered promising serum autoantibody panels with high sensitivity and specificity for PDAC biomarker development.
- Findings highlight the role of specific antibody subclasses and glycoforms in PDAC immune evasion.
More Related Videos
08:30Immunophenotyping of Orthotopic Homograft Syngeneic of Murine Primary KPC Pancreatic Ductal Adenocarcinoma by Flow Cytometry
Published on: October 9, 2018
05:44Isolation of Proximal Fluids to Investigate the Tumor Microenvironment of Pancreatic Adenocarcinoma
Published on: November 5, 2020